These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2835935

  • 1. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application].
    Yamaguchi H.
    Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935
    [Abstract] [Full Text] [Related]

  • 2. Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
    Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ.
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2416-20. PubMed ID: 3031684
    [Abstract] [Full Text] [Related]

  • 3. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
    Martin RF, Kisor R, Schroer D, Eichler G, Filaccio ML.
    Hum Antibodies Hybridomas; 1990 Apr; 1(3):154-9. PubMed ID: 2103359
    [Abstract] [Full Text] [Related]

  • 4. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ, Morrissey DM, Oettgen HF, Old LJ.
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [Abstract] [Full Text] [Related]

  • 5. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
    Houghton AN, Brooks H, Cote RJ, Taormina MC, Oettgen HF, Old LJ.
    J Exp Med; 1983 Jul 01; 158(1):53-65. PubMed ID: 6864164
    [Abstract] [Full Text] [Related]

  • 6. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
    Abdel-wahab ZA, Gillanders WE, Darrow TL, Seigler HF.
    Hum Antibodies Hybridomas; 1992 Jan 01; 3(1):32-9. PubMed ID: 1576321
    [Abstract] [Full Text] [Related]

  • 7. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.
    Hum Antibodies Hybridomas; 1993 Jan 01; 4(1):2-8. PubMed ID: 8381684
    [Abstract] [Full Text] [Related]

  • 8. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C, Puglisi C, Falcone G.
    Eur J Immunol; 1986 May 01; 16(5):584-7. PubMed ID: 3009205
    [Abstract] [Full Text] [Related]

  • 9. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
    Zhang XM, Borrebaeck CA.
    Hum Antibodies Hybridomas; 1990 May 01; 1(1):42-6. PubMed ID: 1966473
    [Abstract] [Full Text] [Related]

  • 10. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S, Walper A, Grunow R, Heym S, Volk HD, von Baehr R.
    Allerg Immunol (Leipz); 1990 May 01; 36(4):359-65. PubMed ID: 1965878
    [Abstract] [Full Text] [Related]

  • 11. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J, Kanzy EJ, Köhler R, Willems WR.
    Behring Inst Mitt; 1986 Jun 01; (80):31-41. PubMed ID: 3019293
    [Abstract] [Full Text] [Related]

  • 12. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E, Tsoukas CD, Vaughan JH, Altman A, Carson DA.
    J Immunol; 1983 Jan 01; 130(1):169-72. PubMed ID: 6292301
    [Abstract] [Full Text] [Related]

  • 13. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
    Watson DB, Burns GF, Mackay IR.
    J Immunol; 1983 May 01; 130(5):2442-7. PubMed ID: 6300247
    [Abstract] [Full Text] [Related]

  • 14. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H, Hirata Y, Sugawara I, Fukuda A, Yoshida TO.
    Behring Inst Mitt; 1985 Dec 01; (78):139-47. PubMed ID: 3008706
    [Abstract] [Full Text] [Related]

  • 15. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 01; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
    Lundgren K, Wahlgren M, Troye-Blomberg M, Berzins K, Perlmann H, Perlmann P.
    J Immunol; 1983 Oct 01; 131(4):2000-3. PubMed ID: 6311902
    [Abstract] [Full Text] [Related]

  • 17. [A strategy for the production of human monoclonal antibodies].
    Chiba J.
    Hum Cell; 1988 Mar 01; 1(1):31-6. PubMed ID: 2856441
    [Abstract] [Full Text] [Related]

  • 18. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
    Glasky MS, Reading CL.
    Hybridoma; 1989 Aug 01; 8(4):377-89. PubMed ID: 2550358
    [Abstract] [Full Text] [Related]

  • 19. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
    León-González G, Cruz C.
    Invest Clin; 2007 Mar 01; 48(1):57-67. PubMed ID: 17432544
    [Abstract] [Full Text] [Related]

  • 20. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T, Kato K, Shiku H, Yamada K.
    Gan To Kagaku Ryoho; 1983 Dec 01; 10(12):2575-81. PubMed ID: 6606396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.